Literature DB >> 134638

T and B lymphocytes in patients with Down's syndrome.

K Reiser, C Whitcomb, K Robinson, M R MacKenzie.   

Abstract

Individuals with Down's syndrome are thought to have abnormalities of immune function. Studies to quantify the number of peripheral blood T and B lymphocytes and serum immunoglobulins in 12 individuals and 12 sex and age matched control subjects were performed. Hepatitis B antigen and antihyroglobulin antibodies as markers of possible immune dysfunction were determined. The numbers of circulating T and B cells, and the level of serum immunoglobulins in children with Down's syndrome did not differ from nonretarded control children. Circulating hepatitis B antigen and antihyroglobulin antibodies were not present. These studies indicated that quantitative abnormalities of T and B cells are not present in children with Down's syndrome. The data did not exclude the existence of qualitative abnormalities.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 134638

Source DB:  PubMed          Journal:  Am J Ment Defic        ISSN: 0002-9351


  4 in total

1.  Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.

Authors:  S Raziuddin; M E Elawad
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

2.  Down's syndrome: changes in protein fractions of blood plasma.

Authors:  J Kedziora; M Soszyński; G Bartosz; H Witas; W Leyko
Journal:  Experientia       Date:  1980-08-15

3.  Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.

Authors:  R Karttunen; T Nurmi; J Ilonen; H M Surcel
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

4.  Natural killer cell function in trisomy-21 (Down's syndrome).

Authors:  T Nurmi; K Huttunen; O Lassila; M Henttonen; A Säkkinen; S L Linna; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.